Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
AssigneeCommissariat A L'energie Atomique Et Aux Energies Alternatives
InventorsFranck Mouthon, Mathieu Charveriat
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of flecainide as an anti-connexin agent. This anti-connexin agent is advantageously used to potentiate the therapeutic effect of various psychotropic drugs. More specifically, the invention provides a combination product containing flecainide and modafinil.
Claims22
A therapeutic composition comprising flecainide and at least one psychotropic drug, wherein said at least one psychotropic drug is modafinil.
A method for enhancing the memory of healthy subjects and/or for maintaining them awake for long-lasting periods of time comprising the administration to said healthy subjects of a) flecainide and b) modafinil, in which said compounds a) and b) are administered simultaneously, separately or in a staggered manner.
A method for potentiating the effects of modafinil, comprising the administration of flecainide as an anti-connexin agent.
Dependencies are inferred from the claim text.